Surgical Treatment of Mandibular Furcations Using a Xenograft With/Without a Collagen Membrane
Treatment of Mandibular Type II Furcations Using Bovine-derived Bone Xenograft With or Without a Collagen Membrane: a Randomized Clinical Trial
1 other identifier
interventional
19
0 countries
N/A
Brief Summary
The aim of the study was to perform a randomized controlled clinical study in order to compare the effects of a bovine derived xenograft (with 10% collagen) + a bioabsorbable membrane (control group, CG) vs a bovine derived xenograft (with 10% collagen) alone (test group, TG) on the surgical treatment of mandibular type II furcation defects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
January 2, 2017
CompletedFirst Submitted
Initial submission to the registry
October 19, 2017
CompletedFirst Posted
Study publicly available on registry
November 27, 2017
CompletedDecember 2, 2017
June 1, 2017
1.4 years
October 19, 2017
November 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Horizontal Probing Attachment Level
PAL-H
6 months
Study Arms (2)
Control group
ACTIVE COMPARATOROpen flap surgery on mandibular type II furcations treated with Bio-oss collagen + Bio-gide
Test group
ACTIVE COMPARATOROpen flap surgery on mandibular type II furcations treated with Bio-oss collagen alone
Interventions
Elevation of a flap in order to access the treated furcation
Eligibility Criteria
You may qualify if:
- Patients diagnosed with chronic periodontitis
- Full-mouth plaque score ≦ 20% (at least eight weeks after initial phase and during the whole treatment)
- Clinical evidence of vestibular or lingual mandibular Class II furcation defects (≧ 3mm of horizontal probing depth)
- Presence of at least 2 mm of keratinized gingiva on the selected tooth surface facing the furcation
- Tooth vitality confirmed by clinical tests (cold testing)
You may not qualify if:
- Presence of any systemic disease
- Smokers
- Devitalized tooth or tooth presenting periapical or pulpar pathology (confirmed with a retro-alveolar radiograph)
- Allergies to any of the products used in the present study
- Pregnant or breastfeeding women
- History or current RX therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The patients didn't know whether they were the control or test group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2017
First Posted
November 27, 2017
Study Start
July 30, 2015
Primary Completion
January 2, 2017
Study Completion
January 2, 2017
Last Updated
December 2, 2017
Record last verified: 2017-06